Literature DB >> 34792835

Segmentation of the Aorta and Pulmonary Arteries Based on 4D Flow MRI in the Pediatric Setting Using Fully Automated Multi-Site, Multi-Vendor, and Multi-Label Dense U-Net.

Takashi Fujiwara1, Haben Berhane2, Michael B Scott2,3, Erin K Englund1, Michal Schäfer4, Brian Fonseca5, Alexander Berthusen1, Joshua D Robinson3,6,7, Cynthia K Rigsby3,7,8, Lorna P Browne1, Michael Markl2,3, Alex J Barker1,9.   

Abstract

BACKGROUND: Automated segmentation using convolutional neural networks (CNNs) have been developed using four-dimensional (4D) flow magnetic resonance imaging (MRI). To broaden usability for congenital heart disease (CHD), training with multi-institution data is necessary. However, the performance impact of heterogeneous multi-site and multi-vendor data on CNNs is unclear.
PURPOSE: To investigate multi-site CNN segmentation of 4D flow MRI for pediatric blood flow measurement. STUDY TYPE: Retrospective. POPULATION: A total of 174 subjects across two sites (female: 46%; N = 38 healthy controls, N = 136 CHD patients). Participants from site 1 (N = 100), site 2 (N = 74), and both sites (N = 174) were divided into subgroups to conduct 10-fold cross validation (10% for testing, 90% for training). FIELD STRENGTH/SEQUENCE: 3 T/1.5 T; retrospectively gated gradient recalled echo-based 4D flow MRI. ASSESSMENT: Accuracy of the 3D CNN segmentations trained on data from single site (single-site CNNs) and data across both sites (multi-site CNN) were evaluated by geometrical similarity (Dice score, human segmentation as ground truth) and net flow quantification at the ascending aorta (Qs), main pulmonary artery (Qp), and their balance (Qp/Qs), between human observers, single-site and multi-site CNNs. STATISTICAL TESTS: Kruskal-Wallis test, Wilcoxon rank-sum test, and Bland-Altman analysis. A P-value <0.05 was considered statistically significant.
RESULTS: No difference existed between single-site and multi-site CNNs for geometrical similarity in the aorta by Dice score (site 1: 0.916 vs. 0.915, P = 0.55; site 2: 0.906 vs. 0.904, P = 0.69) and for the pulmonary arteries (site 1: 0.894 vs. 0.895, P = 0.64; site 2: 0.870 vs. 0.869, P = 0.96). Qs site-1 medians were 51.0-51.3 mL/cycle (P = 0.81) and site-2 medians were 66.7-69.4 mL/cycle (P = 0.84). Qp site-1 medians were 46.8-48.0 mL/cycle (P = 0.97) and site-2 medians were 76.0-77.4 mL/cycle (P = 0.98). Qp/Qs site-1 medians were 0.87-0.88 (P = 0.97) and site-2 medians were 1.01-1.03 (P = 0.43). Bland-Altman analysis for flow quantification found equivalent performance. DATA
CONCLUSION: Multi-site CNN-based segmentation and blood flow measurement are feasible for pediatric 4D flow MRI and maintain performance of single-site CNNs. LEVEL OF EVIDENCE: 3 TECHNICAL EFFICACY: Stage 2.
© 2021 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  congenital heart diseases; deep learning; four-dimensional flow; pediatrics

Mesh:

Year:  2021        PMID: 34792835      PMCID: PMC9106805          DOI: 10.1002/jmri.27995

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   5.119


  18 in total

1.  4D flow cardiac magnetic resonance in children and adults with congenital heart disease: Clinical experience in a high volume center.

Authors:  Marc-Antoine Isorni; Louis Moisson; Nidal Ben Moussa; Sébastien Monnot; Francesca Raimondi; Régine Roussin; Angèle Boet; Isabelle van Aerschot; Emmanuelle Fournier; Sarah Cohen; Meriem Kara; Sébastien Hascoet
Journal:  Int J Cardiol       Date:  2020-07-24       Impact factor: 4.164

2.  Fully automated 3D aortic segmentation of 4D flow MRI for hemodynamic analysis using deep learning.

Authors:  Haben Berhane; Michael Scott; Mohammed Elbaz; Kelly Jarvis; Patrick McCarthy; James Carr; Chris Malaisrie; Ryan Avery; Alex J Barker; Joshua D Robinson; Cynthia K Rigsby; Michael Markl
Journal:  Magn Reson Med       Date:  2020-03-13       Impact factor: 4.668

3.  Deep learning for segmentation of brain tumors: Impact of cross-institutional training and testing.

Authors:  Ehab A AlBadawy; Ashirbani Saha; Maciej A Mazurowski
Journal:  Med Phys       Date:  2018-02-08       Impact factor: 4.071

4.  Anatomical and pathophysiological classification of congenital heart disease.

Authors:  Gaetano Thiene; Carla Frescura
Journal:  Cardiovasc Pathol       Date:  2010-05-13       Impact factor: 2.185

Review 5.  4D flow MRI applications in congenital heart disease.

Authors:  Judy Rizk
Journal:  Eur Radiol       Date:  2020-09-01       Impact factor: 5.315

6.  Towards the improved quantification of in vivo abnormal wall shear stresses in BAV-affected patients from 4D-flow imaging: Benchmarking and application to real data.

Authors:  F Piatti; S Pirola; M Bissell; I Nesteruk; F Sturla; A Della Corte; A Redaelli; E Votta
Journal:  J Biomech       Date:  2016-11-11       Impact factor: 2.712

7.  Atlas-based analysis of 4D flow CMR: automated vessel segmentation and flow quantification.

Authors:  Mariana Bustamante; Sven Petersson; Jonatan Eriksson; Urban Alehagen; Petter Dyverfeldt; Carl-Johan Carlhäll; Tino Ebbers
Journal:  J Cardiovasc Magn Reson       Date:  2015-10-05       Impact factor: 5.364

8.  Automated 3D segmentation and diameter measurement of the thoracic aorta on non-contrast enhanced CT.

Authors:  Zahra Sedghi Gamechi; Lidia R Bons; Marco Giordano; Daniel Bos; Ricardo P J Budde; Klaus F Kofoed; Jesper Holst Pedersen; Jolien W Roos-Hesselink; Marleen de Bruijne
Journal:  Eur Radiol       Date:  2019-01-23       Impact factor: 5.315

9.  Normal values for aortic diameters in children and adolescents--assessment in vivo by contrast-enhanced CMR-angiography.

Authors:  Thomas Kaiser; Christian J Kellenberger; Manuela Albisetti; Eva Bergsträsser; Emanuela R Valsangiacomo Buechel
Journal:  J Cardiovasc Magn Reson       Date:  2008-12-05       Impact factor: 5.364

10.  Metrics for evaluating 3D medical image segmentation: analysis, selection, and tool.

Authors:  Abdel Aziz Taha; Allan Hanbury
Journal:  BMC Med Imaging       Date:  2015-08-12       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.